March 17, 2020 / 10:51 AM / 23 days ago

BRIEF-Avivagen Accelerates Plans For Commercial Launch Of Its Oxc-Beta Technology For Human Use In Response To Covid-19

March 17 (Reuters) - Avivagen Inc:

* AVIVAGEN ACCELERATES PLANS FOR COMMERCIAL LAUNCH OF ITS OXC-BETA™ TECHNOLOGY FOR HUMAN USE IN RESPONSE TO COVID-19 PANDEMIC Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below